{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:57:53Z","timestamp":1788951473221,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T00:00:00Z","timestamp":1173139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2007,3,29]]},"DOI":"10.1007\/s00210-007-0146-x","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T11:58:21Z","timestamp":1173095901000},"page":"205-220","source":"Crossref","is-referenced-by-count":27,"title":["The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone"],"prefix":"10.1007","volume":"375","author":[{"given":"D. T.","family":"Beattie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cheruvu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Johnson-Rabidoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vickery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,6]]},"reference":[{"key":"146_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/bj2950263","volume":"295","author":"H Ammer","year":"1993","unstructured":"Ammer H, Schulz R (1993) Alteration in the expression of G-proteins and regulation of adenylate cyclase in human neuroblastoma SH-SY5Y cells chronically exposed to low-efficacy \u03bc-opioids. Biochem J 295:263\u2013271","journal-title":"Biochem J"},{"key":"146_CR2","first-page":"48","volume":"14","author":"O Arunlakshana","year":"1959","unstructured":"Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48\u201358","journal-title":"Br J Pharmacol"},{"key":"146_CR3","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1523\/JNEUROSCI.23-33-10515.2003","volume":"23","author":"CP Bailey","year":"2003","unstructured":"Bailey CP, Couch D, Johnson E, Griffiths K, Kelly E, Henderson G (2003) \u03bc-Opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine. J Neurosci 23:10515\u201310520","journal-title":"J Neurosci"},{"key":"146_CR4","doi-asserted-by":"crossref","first-page":"27513","DOI":"10.1074\/jbc.274.39.27513","volume":"274","author":"JAJ Becker","year":"1999","unstructured":"Becker JAJ, Wallace A, Garzon A, Ingallinella P, Bianchi E, Cortese R, Simonin F, Kieffer BL, Pessi A (1999) Ligands for \u03ba-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library. J Biol Chem 274:27513\u201327522","journal-title":"J Biol Chem"},{"key":"146_CR5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-3011.2005.00216.x","volume":"65","author":"MA Bennett","year":"2005","unstructured":"Bennett MA, Murray TF, Aldrich JV (2005) Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist. J Pept Res 65:322\u2013332","journal-title":"J Pept Res"},{"key":"146_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-2999(93)90196-O","volume":"241","author":"PJ Brent","year":"1993","unstructured":"Brent PJ, Chahl LA, Cantarella PA, Kavanagh C (1993) The \u03ba-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs. Eur J Pharmacol 241:149\u2013156","journal-title":"Eur J Pharmacol"},{"key":"146_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0028-3908(85)90072-3","volume":"24","author":"DR Brown","year":"1985","unstructured":"Brown DR, Goldberg LI (1985) The use of quaternary narcotic antagonists in opiate research. Neuropharmacology 24:181\u2013191","journal-title":"Neuropharmacology"},{"key":"146_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2982.2005.00640.x","volume":"17","author":"M Camilleri","year":"2005","unstructured":"Camilleri M (2005) Alvimopan, a selective peripherally acting \u03bc-opioid antagonist. Neurogastroenterol Motil 17:157\u2013165","journal-title":"Neurogastroenterol Motil"},{"key":"146_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.08.008","volume":"520","author":"JD Cassel","year":"2005","unstructured":"Cassel JD, Daubert JD, Dehaven RN (2005) [3H]Alvimopan binding to the \u03bc opioid receptor: Comparative binding kinetics of opioid antagonists. Eur J Pharmacol 520:29\u201336","journal-title":"Eur J Pharmacol"},{"key":"146_CR10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/mol.54.6.949","volume":"54","author":"S Chakrabarti","year":"1998","unstructured":"Chakrabarti S, Rivera M, Yan SZ, Tang WJ, Gintzler AR (1998) Chronic morphine augments % MathType!MTEF!2!1!+-% feaaeaart1ev0aaatCvAUfeBSjuyZL2yd9gzLbvyNv2CaerbbjxAHX% garmWu51MyVXgaruWqVvNCPvMCG4uz3bqee0evGueE0jxyaibaieYd% f9irVeeu0dXdh9vqqj-hEeeu0xXdbba9frFj0-OqFfea0dXdd9vqaq% -JfrVkFHe9pgea0dXdar-Jb9hs0dXdbPYxe9vr0-vr0-vqpWqaaeaa% biGaciaacaqabeaadaqadqaaaOqaamaalyaabaGaae4ramaaBaaale% aacaqGYoGaae4SdaqabaaakeaacaqGhbWaaSbaaSqaaiaabohacqaH% Xoqyaeqaaaaaaaa!395E! $${{\\text{G}}_{{{\\text{ $ \\beta $ $ \\gamma $ }}}} } \\mathord{\\left\/ {\\vphantom {{{\\text{G}}_{{{\\text{ $ \\beta $ $ \\gamma $ }}}} } {{\\text{G}}_{{{\\text{s}}\\alpha }} }}} \\right. \\kern-\\nulldelimiterspace} {{\\text{G}}_{{{\\text{s}}\\alpha }} }$$ stimulation of adenylyl cyclase: relevance to opioid tolerance. Mol Pharmacol 54:655\u2013662","journal-title":"Mol Pharmacol"},{"key":"146_CR11","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"YC Cheng","year":"1973","unstructured":"Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099\u20133108","journal-title":"Biochem Pharmacol"},{"key":"146_CR12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1476-5381.1981.tb08747.x","volume":"73","author":"HOJ Collier","year":"1981","unstructured":"Collier HOJ, Cuthbert NJ, Francis DL (1981) Model of opiate dependence in the guinea-pig isolated ileum. Br J Pharmacol 73:921\u2013932","journal-title":"Br J Pharmacol"},{"key":"146_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/clpt.1992.106","volume":"52","author":"JA Culpepper-Morgan","year":"1992","unstructured":"Culpepper-Morgan JA, Inturrisi CE, Portenoy RK, Foley K, Houde RW, Marsh F, Kreek MJ (1992) Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther 52:90\u201395","journal-title":"Clin Pharmacol Ther"},{"key":"146_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0163-7258(95)02053-5","volume":"69","author":"A Luca De","year":"1996","unstructured":"De Luca A, Coupar IM (1996) Insights into opioid action in the intestinal tract. Pharmacol Ther 69:103\u2013115","journal-title":"Pharmacol Ther"},{"key":"146_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2004.04.050","volume":"494","author":"PJ Emmerson","year":"2004","unstructured":"Emmerson PJ, McKinzie JH, Surface PL, Suter TM, Mitch CH, Statnick MA (2004) Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists. Eur J Pharmacol 494:121\u2013130","journal-title":"Eur J Pharmacol"},{"key":"146_CR16","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1016\/S0002-9610(01)00783-8","volume":"182","author":"JF Foss","year":"2001","unstructured":"Foss JF (2001) A review of the potential role of methylnaltrexone in opioid bowel dysfunction. Am J Surg 182:19S\u201326S","journal-title":"Am J Surg"},{"key":"146_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clpt.2004.12.175","volume":"77","author":"JF Foss","year":"2005","unstructured":"Foss JF, Schmith VD, Wallin BA, Du W, Melikian AP (2005) Alvimopan (Entereg\u2122), a novel opioid antagonist, achieves active systemic concentrations. Clin Pharmacol Ther 77:74","journal-title":"Clin Pharmacol Ther"},{"key":"146_CR18","unstructured":"Goldberg LI, Merz H, Stockhaus K (1979) Quaternary derivatives of noroxymorphone which relieve intestinal immobility. US Patent 4176186"},{"issue":"Suppl 2","key":"146_CR19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1743-3150.2004.00555.x","volume":"16","author":"B Greenwood-Van Meerveld","year":"2004","unstructured":"Greenwood-Van Meerveld B, Gardner CJ, Little PJ, Hicks GA, Dehaven-Hudkins DL (2004) Preclinical studies of opioids and opioid antagonists on gastrointestinal function. Neurogastroenterol Motil 16(Suppl 2):46\u201353","journal-title":"Neurogastroenterol Motil"},{"key":"146_CR20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0143-4179(85)90034-4","volume":"5","author":"LD Hirning","year":"1985","unstructured":"Hirning LD, Mosberg HI, Hurst R, Hruby VJ, Burks TF, Porreca F (1985) Studies in vitro with ICI 174,864, [d-Pen2, d-Pen5]-enkephalin (DPDPE) and [d-Ala2, NMePhe4, Gly-ol]-enkephalin (DAGO). Neuropeptides 5:383\u2013386","journal-title":"Neuropeptides"},{"key":"146_CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0306-4522(87)90145-X","volume":"21","author":"SM Johnson","year":"1987","unstructured":"Johnson SM, Williams JT, Costa M, Furness JB (1987) Naloxone-induced depolarization and synaptic activation of myenteric neurons in morphine-dependent guinea pig ileum. Neurosci 21:595\u2013602","journal-title":"Neurosci"},{"key":"146_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(00)00208-9","volume":"396","author":"RM Jones","year":"2000","unstructured":"Jones RM, Portoghese PS (2000) 5\u2032-Guanidinonaltrindole, a highly selective and potent \u03ba-opioid receptor antagonist. Eur J Pharmacol 396:49\u201352","journal-title":"Eur J Pharmacol"},{"key":"146_CR23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1096\/fasebj.9.7.7737460","volume":"9","author":"RJ Knapp","year":"1995","unstructured":"Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR, Yamamura HI (1995) Molecular biology and pharmacology of cloned opioid receptors. FASEB J 9:516\u2013525","journal-title":"FASEB J"},{"key":"146_CR24","first-page":"1284","volume":"277","author":"RJ Knapp","year":"1996","unstructured":"Knapp RJ, Santoro G, De Leon IA, Lee KB, Edsall SA, Waite S, Malatynska E, Varga E, Calderon SN, Rice KC, Rothman RB, Porreca F, Roeske WR, Yamamura HI (1996) Structure-activity relationships for SNC 80 and related compounds at cloned human delta and mu opioid receptors. J Pharmacol Exp Ther 277:1284\u20131291","journal-title":"J Pharmacol Exp Ther"},{"key":"146_CR25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/00498258909043176","volume":"19","author":"AN Kotake","year":"1989","unstructured":"Kotake AN, Kuwahara SK, Burton E, McCoy CE, Goldberg LI (1989) Variations in demethylation of N-methylnaltrexone in mice, rats, dogs and humans. Xenobiotica 19:1247\u20131254","journal-title":"Xenobiotica"},{"key":"146_CR26","first-page":"544","volume":"249","author":"TH Kramer","year":"1989","unstructured":"Kramer TH, Shook JE, Kazmierski W, Ayres EA, Wire WS, Hruby VJ, Burks TF (1989) Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. J Pharmacol Exp Ther 249:544\u2013551","journal-title":"J Pharmacol Exp Ther"},{"key":"146_CR27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","volume":"63","author":"A Kurz","year":"2003","unstructured":"Kurz A, Sessler DI (2003) Opioid-induced bowel dysfunction: Pathophysiology and potential new therapies. Drugs 63:649\u2013671","journal-title":"Drugs"},{"key":"146_CR28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-2999(85)90431-5","volume":"109","author":"RA Lahti","year":"1985","unstructured":"Lahti RA, Mickelson MM, McCall JM, Voigtlander PF (1985) [3H]U-69593, a highly selective ligand for the opioid kappa receptor. Eur J Pharmacol 109:281\u2013284","journal-title":"Eur J Pharmacol"},{"key":"146_CR29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1476-5381.1981.tb08739.x","volume":"73","author":"M Lujan","year":"1981","unstructured":"Lujan M, Rodriguez R (1981) Pharmacological characterization of opiate physical ependence in the isolated ileum of the guinea-pig. Br J Pharmacol 73:859\u2013866","journal-title":"Br J Pharmacol"},{"key":"146_CR30","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1021\/jm000511w","volume":"44","author":"S McLamore","year":"2001","unstructured":"McLamore S, Ullrich T, Rothman RB, Xu H, Dersch C, Coop A, Davis P, Porreca F, Jacobson AE, Rice KC (2001) Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5 \u03b1-epoxy-3,14-dihydroxy-6,7:2\u2032,3\u2032-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy. J Med Chem 44:1471\u20131474","journal-title":"J Med Chem"},{"key":"146_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(99)00185-2","volume":"84","author":"W Meissner","year":"2000","unstructured":"Meissner W, Schmidt U, Hartmann M, Kath R, Reinhart K (2000) Oral naloxone reverses opioid-associated constipation. Pain 84:105\u2013109","journal-title":"Pain"},{"key":"146_CR32","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bjp.0703659","volume":"131","author":"MK Mundey","year":"2000","unstructured":"Mundey MK, Ali A, Mason R, Wilson VG (2000) Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by \u03bc-opioid receptor antagonists in the presence of, and following exposure to, morphine. Br J Pharmacol 131:893\u2013902","journal-title":"Br J Pharmacol"},{"key":"146_CR33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1254\/jjp.78.83","volume":"78","author":"H Nishiwaki","year":"1998","unstructured":"Nishiwaki H, Saitoh N, Nishio H, Takeuchi T, Hata F (1998) Inhibitory effect of endomorphin-1 and -2 on acetylcholine release from myenteric plexus of guinea pig ileum. Jap J Pharmacol 78:83\u201386","journal-title":"Jap J Pharmacol"},{"key":"146_CR34","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/S0002-9610(01)00782-6","volume":"182","author":"M Pappagallo","year":"2001","unstructured":"Pappagallo M (2001) Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 182:11S\u201318S","journal-title":"Am J Surg"},{"key":"146_CR35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpain.2004.12.001","volume":"6","author":"DM Paulson","year":"2005","unstructured":"Paulson DM, Kennedy DT, Donovick RA, Carpenter RL, Cherubini M, Techner L, Du W, Ma Y, Schmidt WK, Wallin B, Jackson D (2005) Alvimopan: an oral, peripherally acting, \u03bc-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction\u2014a 21-day treatment-randomized clinical trial. J Pain 6:184\u2013192","journal-title":"J Pain"},{"key":"146_CR36","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.lfs.2004.10.024","volume":"76","author":"W Sad\u00e9e","year":"2005","unstructured":"Sad\u00e9e W, Wang D, Bilsky EJ (2005) Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities. Life Sci 76:1427\u20131437","journal-title":"Life Sci"},{"key":"146_CR37","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9610(01)00784-X","volume":"182","author":"WK Schmidt","year":"2001","unstructured":"Schmidt WK (2001) Alvimopan (ADL 8-2698) is a novel peripheral-opioid antagonist. Am J Surg 182:27S\u201338S","journal-title":"Am J Surg"},{"key":"146_CR38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clpt.2004.12.080","volume":"77","author":"VD Schmith","year":"2005","unstructured":"Schmith VD, Garnett W, Barr WH, Kelleher D, Young M, Sanderlin G, Coots S, Agyemang A, Dukes G (2005) Alvimopan pharmacokinetics (PK) & pharmacodynamics (PD) in patients with chronic constipation (CC). Clin Pharmacol Ther 77:49","journal-title":"Clin Pharmacol Ther"},{"key":"146_CR39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjp.0704527","volume":"135","author":"A Shahbazian","year":"2002","unstructured":"Shahbazian A, Heinemann A, Schmidhammer H, Beubler E, Holzer-Petsche U, Holzer P (2002) Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine. Br J Pharmacol 135:741\u2013750","journal-title":"Br J Pharmacol"},{"key":"146_CR40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2003.09.043","volume":"482","author":"MA Statnick","year":"2003","unstructured":"Statnick MA, Suter TM, Gackenheimer SL, Emmerson PJ, Quimby SJ, Gehlert DR, Wheeler WJ, Mitch CH (2003) Na+-dependent high affinity binding of [3H]LY515300, a 3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid receptor inverse agonist. Eur J Pharmacol 482:139\u2013150","journal-title":"Eur J Pharmacol"},{"key":"146_CR41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/PL00005313","volume":"358","author":"M Tonini","year":"1998","unstructured":"Tonini M, Fiori E, Balestra B, Spelta V, D\u2019Agostino G, Di Nucci A, Brecha NC, Sternini C (1998) Endomorphin-1 and endomorphin-2 activate \u03bc-opioid receptors in myenteric neurons of the guinea-pig small intestine. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 358:686\u2013689","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"146_CR42","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1476-5381.1995.tb13334.x","volume":"114","author":"P Valeri","year":"1995","unstructured":"Valeri P, Morrone LA, Romanelli L, Amico MC (1995) Acute withdrawal after bremazocine and the interaction between \u03bc- and \u03ba-opioid receptors in isolated gut tissues. Br J Pharmacol 114:1206\u20131210","journal-title":"Br J Pharmacol"},{"key":"146_CR43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002820-199808000-00011","volume":"21","author":"G Vanegas","year":"1998","unstructured":"Vanegas G, Ripamonti C, Sbanotto A, De Conno F (1998) Side effects of morphine administration in cancer patients. Cancer Nurs 21:289\u2013297","journal-title":"Cancer Nurs"},{"key":"146_CR44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0885-3924(90)90031-E","volume":"5","author":"TD Walsh","year":"1990","unstructured":"Walsh TD (1990) Prevention of opioid side effects. J Pain Symptom Manage 5:362\u2013367","journal-title":"J Pain Symptom Manage"},{"key":"146_CR45","first-page":"45","volume":"27","author":"TD Walsh","year":"2000","unstructured":"Walsh TD (2000) Pharmacological management of cancer pain. Semin Oncol 27:45\u201363","journal-title":"Semin Oncol"},{"key":"146_CR46","first-page":"339","volume":"54","author":"D Wang","year":"1994","unstructured":"Wang D, Bilsky EJ, Porecca F, Sad\u00e9e W (1994) Constitutive \u03bc opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci 54:339\u2013350","journal-title":"Life Sci"},{"key":"146_CR47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1021\/jo951403y","volume":"61","author":"JA Werner","year":"1996","unstructured":"Werner JA, Cerbone LR, Frank SA, Ward JA, Labib P, Tharp-Taylor RW, Ryan CR (1996) Synthesis of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists: application of the cis-thermal elimination of carbonates to alkaloid synthesis. J Org Chem 61:587\u2013597","journal-title":"J Org Chem"},{"key":"146_CR48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.sla.0000141158.27977.66","volume":"240","author":"BG Wolff","year":"2004","unstructured":"Wolff BG, Michelassi F, Gerkin T, Techner L, Gabriel K, Du W, Wallin BA (2004) Alvimopan, a novel, peripherally acting \u03bc opioid antagonist. Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg 240:728\u2013735","journal-title":"Ann Surg"},{"key":"146_CR49","first-page":"111","volume":"2","author":"CS Yuan","year":"2004","unstructured":"Yuan CS (2004) Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects. J Support Oncol 2:111\u2013122","journal-title":"J Support Oncol"},{"key":"146_CR50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(95)00018-G","volume":"276","author":"CS Yuan","year":"1995","unstructured":"Yuan CS, Foss JF, Moss J (1995) Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human tissue. Eur J Pharmacol 276:107\u2013111","journal-title":"Eur J Pharmacol"},{"key":"146_CR51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0304-3959(99)00162-1","volume":"83","author":"CS Yuan","year":"1999","unstructured":"Yuan CS, Foss JF, O\u2019Connor M, Osinski J, Roizen MF, Moss J (1999) Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study. Pain 83:631\u2013635","journal-title":"Pain"},{"key":"146_CR52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.283.3.367","volume":"283","author":"CS Yuan","year":"2000","unstructured":"Yuan CS, Foss JF, O\u2019Connor M, Osinski J, Karrison T, Moss J, Roizen M (2000) Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA 283:367\u2013372","journal-title":"JAMA"},{"key":"146_CR53","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","volume":"386","author":"JE Zadina","year":"1997","unstructured":"Zadina JE, Hackler L, Ge LJ, Kastin AJ (1997) A potent and selective endogenous agonist for the \u03bc-opiate receptor. Nature 386:499\u2013502","journal-title":"Nature"},{"key":"146_CR54","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1021\/jm00041a003","volume":"37","author":"DM Zimmerman","year":"1994","unstructured":"Zimmerman DM, Gidda JS, Cantrell BE, Schoepp DD, Johnson BG, Leander JD (1994) Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders. J Med Chem 37:2262\u20132265","journal-title":"J Med Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0146-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-007-0146-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0146-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T16:59:50Z","timestamp":1628528390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-007-0146-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3,29]]}},"alternative-id":["146"],"URL":"https:\/\/doi.org\/10.1007\/s00210-007-0146-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,6]]}}}